Pregabalin Capsule
Product Images NDC 63629-8208

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 63629-8208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298208)

This is a description of Pregabalin Capsules, USP with a dosage of 200mg per capsule. It is advised to keep this drug and all other drugs out of the reach of children and store it at a temperature between 20° to 25° C with excursions permitted to 15° to 30° C. The package contains 30 capsules and its NDC number is 63629-8208-01. This drug is only available via prescription.*

FDA Label Image

Label (Lbl6362982082)

This text is a package label with information on a medication called Lyrica 200mg (CV) Capsule produced by ScieGen Pharmaceuticals Inc. It provides details on the quantity (#30), expiration date (MM/YY), NDC number (6362982081), and recommended storage temperature (20°-25°C or 68°-77°F). The label also includes a warning to keep all drugs out of reach of children.*

FDA Label Image

Figure 1 (Pregabalin Fig01)

The text seems to represent some statistics regarding the improvement of patients, with numbers indicating percentages of improvement and the title "Percent Improvement in Pain from Baseline". However, the formatting is inconsistent and there are non-numeric characters such as "Shemmm it" and "@ 2 2o 2 20 20 2 20 W". Therefore, it is not possible to generate a clear and useful description based on this text.*

FDA Label Image

Figure 2 (Pregabalin Fig02)

This is a report showing the percentage of patients that have improved after taking Pregabalin at a dosage of 160mg for three days. The report also includes a chart showing the percent improvement in pain from baseline.*

FDA Label Image

Figure 3 (Pregabalin Fig03)

This appears to be a chart showing different medications and their dosage and frequency, along with the percentage of patients who experienced improvement in pain. However, the chart is not readable in its current state due to errors and missing information.*

FDA Label Image

Figure 4 (Pregabalin Fig04)

FDA Label Image

Figure 5 (Pregabalin Fig05)

This is a summary of a study that compares the efficacy of Fregabalin, Pregataiin, and Placebo in treating pain. The text provides the dosages administered to patients and a table which shows the percentage of patients who experienced improvement in their pain after treatment. The numbers in the table range from 0.8 to 100, indicating the level of improvement in pain. The text also shows the baseline pain scores and the number of times the medications were taken daily.*

FDA Label Image

Figure 6 (Pregabalin Fig06)

FDA Label Image

Figure 7 (Pregabalin Fig07)

FDA Label Image

Figure 9 (Pregabalin Fig08)

FDA Label Image

Figure 10 (Pregabalin Fig09)

This appears to be a chart or a table showing estimated percentages of subjects without LTR ("LTR" might mean "long terminal repeat", "lost to follow-up", or something else, but the meaning cannot be determined from the given text). The numbers range from 0% to 100% in increments of 10%. The chart also mentions "Progabain" and "Placebo", which might be two treatments being compared in a study, but this cannot be confirmed without additional context. The numbers at the bottom appear to indicate the duration of the study in days.*

FDA Label Image

Figure 11 (Pregabalin Fig10)

FDA Label Image

Figure 12 (Pregabalin Fig11)

FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

This is a formula to calculate the creatinine clearance (CLCT) of a patient using their age, weight, and serum creatinine level. The formula is [(140 - age in years) x weight in kg] divided by (72 x serum creatinine level in mg/dL). For female patients, the result is then multiplied by 0.85.*

FDA Label Image

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.